Zymosan
Term · Oncology and biomedicine · MLC-T-ONC-017721
An insoluble beta-1,3-glucan polysaccharide derived from, and structural component of, yeast cell walls, with potential immunostimulating activity. Upon administration, zymosan targets, binds to and activates certain Toll-like receptors, primarily TLR type 2 (TLR-2), on leukocytes and dectin-1 on macrophages. Activation of TLR2 and dectin-1 stimulates the release of pro-inflammatory mediators, and enhances innate immune responses.
| Identifier | MLC-T-ONC-017721 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | ZM |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017721",
"term": "Zymosan",
"field": "Oncology and biomedicine",
"definition": "An insoluble beta-1,3-glucan polysaccharide derived from, and structural component of, yeast cell walls, with potential immunostimulating activity. Upon administration, zymosan targets, binds to and activates certain Toll-like receptors, primarily TLR type 2 (TLR-2), on leukocytes and dectin-1 on macrophages. Activation of TLR2 and dectin-1 stimulates the release of pro-inflammatory mediators, and enhances innate immune responses.",
"abbreviation": "ZM",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/zymosan/"
}
Record 17,712 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.